Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced that a new indication application of its trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) sacituzumab ...

Carlisle girl Skye Watson, 11, is cancer-free after months of chemotherapy and surgery for rare Anaplastic Large Cell Lymphoma, ringing the bell.

Carlisle girl Skye Watson, 11, is cancer-free after months of chemotherapy and surgery for rare Anaplastic Large Cell Lymphoma, ringing the bell.

Brentuximab vedotin has transformed the outlook for patients with CD30-positive lymphomas, but the antibody-drug conjugate ...

A fulminant, disseminated, EBV-negative extranodal NK/T-cell lymphoma in a previously healthy infant was diagnosed only after ...

T-Cell Lymphoma Clinical Trial Drug Development Pipeline Expands With Contributions From 90+ Key Companies Delveinsight. The T-Cell Lymphoma clinical trial analysis report delivers important insights ...

PTCL success hinges on biomarker-aligned therapies, clear superiority, broad subtype reach, and scalable commercialization, supported by uptake, pricing, access, and competitive insights.Dublin, Oct.

Prioritize next-generation ALK inhibitors with CNS penetration and resistance coverage, supported by molecular testing, differentiated safety, strategic access and KOL-led adoption.Dublin, Oct. 14, ...

Most lumps, fevers and tiredness in young people have harmless causes, but persistent symptoms could point to something more serious that needs medical attention.

Recognition of mixed autoimmune hemolytic anemia can help clinicians avoid treatment strategies appropriate for only warm or cold disease. A 69-year-old man with anaplastic B-cell lymphoma and ...

Recognition of mixed autoimmune hemolytic anemia can help clinicians avoid treatment strategies appropriate for only warm or cold disease. A 69-year-old man with anaplastic B-cell lymphoma and ...